EDWINA PARRISH-LITTLEJOHN: Open Payments
NPI 1235101528 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 15 payments from 7 companies in 2025. Trend: 2023 $37 · 2024 $1,036 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 5 | $281 |
| UCB, Inc. | 3 | $66 |
| ACADIA Pharmaceuticals Inc | 2 | $46 |
| 180 Medical, Inc. | 2 | $34 |
| Genentech USA, Inc. | 1 | $29 |
| Neurelis, Inc. | 1 | $28 |
| Biogen, Inc. | 1 | $26 |
Products named: Mavenclad, NUPLAZID, Ocrevus, VALTOCO, Fintepla, VUMERITY, Rystiggo, GENTLECATH.
Industry payments across MO — which companies pay providers there.
